Coronavirus has killed more than 40,000 people in the UK, with the number continuing to rise. But, scientists have made a breakthrough in the search for a COVID-19 vaccine.
{%=o.title%} ]]>
The NHS has been backed to immediately use the dexamethasone steroid as a treatment for coronavirus.
The drug has been revealed to lower the risk of coronavirus death by as much as 35 percent in patients on ventilation.
The government has started to secure extra supplies of dexamethasone, with enough treatment available today for up to 200,000 people.
Health Secretary of State Matt Hancock has thanked the Oxford University scientists for their breakthrough.
READ MORE: Coronavirus latest – scientists reveal ‘breakthrough’ treatment
Coronavirus vaccine: Treatment for COVID-19 backed for immediate NHS use (Image: GETTY Images)
“I’m absolutely delighted that today we can announce the world’s first successful clinical trial for a treatment for COVID-19,” he said.
“This astounding breakthrough is testament to the incredible work being done by our scientists behind the scenes.
“From today the standard treatment for COVID-19 will include dexamethasone, helping save thousands of lives while we deal with this terrible virus.
“Guided by the science, the UK is leading the way in the global fight against coronavirus – with the best clinical trials, the best vaccine development and the best immunology research in the world.”
DON’T MISS
Coronavirus update: Lyme disease symptoms may be mistaken for COVID-19 [SIGNS]
Coronavirus warning – what colour are your lips? Hidden signs of COVID [SYMPTOMS]
Coronavirus warning – ‘The single most effective way’ to avoid COVID [QUOTES]
Dexamethasone is an anti-inflammatory drug that’s relatively cheap to produce.
Coronavirus patients that are currently on oxygen, including ventilators, will be given dexamethasone as a treatment from today.
READ RELATED: Nurses are wrongly being banned from drinking WATER on hospital wards amid heatwave
It comes after the Oxford University RECOVERY trial became the first clinical trial to find a significant treatment for COVID-19.
The research is yet to be peer-reviewed, but Deputy Chief Medical Officer, Professor Jonathan Van-Tam, has admitted that the findings were “very encouraging”.
Coronavirus symptoms: The government has advised the public to remain indoors (Image: EXPRESS)
Professor Van Tam said: “The RECOVERY trial is an outstanding example of the UK leading the world with an impressive study capable of delivering robust answers to critical questions. Although these data have not yet been peer-reviewed.
“On the dexamethasone findings, this is very encouraging because the signal on reduced mortality applies to many of the patients admitted to hospitals and the drug is comparatively low priced and available worldwide.
“The positive findings on dexamethasone follow the disappointing findings on hydroxychloroquine. Together these two results illustrate the power of properly conducted clinical trials and the inherent danger of assuming things work without robust data.
“Whilst tempting to do otherwise, it is always better to wait for the evidence.”
Clinical trials that included hydroxychloroquine as a potential coronavirus treatment have been suspended.
The decision to suspend trials followed a series of concerns by scientists over patient welfare.
Two separate clinical trials, including the UK’s RECOVERY trial, found no convincing evidence that hydroxychloroquine lowered the risk of death in COVID-19 patients.
During the daily press briefing at Downing Street, the Chief Scientific Advisor, Patrick Vallance, welcomed the research findings.
But, he insisted that more work is still needed to build on these breakthrough findings.
“This is the first medicine that’s been proven to reduce death in any group with COVID,” said Vallance.
“This is the start of something important. It shows it is possible to reduce the inflammation and outcome of those in hospital.”
Source: Daily Express
